Accurately distinguishing HER2-low and ultralow expression in metastatic breast cancer (mBC) is critical, yet it presents unique challenges for pathologists. Traditional binary HER2 classifications no longer meet clinical needs, as the availability of antibody-drug conjugates (ADCs) now depend on more …
Patients with chronic diseases frequently experience comorbid behavioral health disorders that complicate disease management, worsen outcomes, and increase health care utilization. Despite evidence linking psychiatric illnesses (e.g., depression, anxiety, bipolar disorder, schizophrenia) to poor adherence and higher mortality, behavioral health …
The emergence of HER2-low and ultralow classifications in mBC (mBC) is reshaping treatment options, offering new hope for patients who were once considered ineligible for targeted therapy. Yet many clinicians face uncertainty about how to appropriately define these new phenotypes …
Although it is a rare immune-mediated neuropathological condition, chronic inflammatory demyelinating polyneuropathy (CIDP) is associated with significant morbidity and reduced quality of life. The development of new guidelines from the European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) on diagnosing and …
Spanish-speaking and Latine populations in the U.S. experience significant health disparities driven by language barriers, limited access to culturally responsive care, and systemic factors such as documentation status and insurance limitations. Pharmacists play a critical role in improving medication understanding, …
This activity focuses on one of the most persistent challenges in global hepatitis management: ensuring that patients who test positive for hepatitis B (HBV), hepatitis C (HCV), or hepatitis D (HDV) are successfully connected to ongoing care. Despite the availability …
The final program in the Linking Knowledge to Action: Empowering HCPs in Screening and Treatment of Patients Across the Viral Hepatitis Spectrum series focuses on practical and equitable approaches to meeting the World Health Organization’s 2030 hepatitis elimination targets. This …
Hospitalized patients with SARS-CoV-2 infection remain at significant risk of clinical deterioration and death, particularly among those with comorbidities or requiring advanced respiratory support. Despite evolving therapeutic options and published clinical guidelines, real-world implementation of SARS-CoV-2 treatment recommendations remains inconsistent, …
Timely diagnosis and prompt initiation of treatment are critical for optimizing outcomes in patients with SARS-CoV-2 infection. Yet, despite advancements in testing and therapeutic strategies, diagnostic delays and clinical missteps persist within the inpatient setting, potentially leading to worsened prognosis …